Financials KPC Pharmaceuticals,Inc.

Equities

End-of-day quote Shanghai S.E. Other stock markets 18:00:00 2024-07-14 EDT			5-day change	1st Jan Change
16.99 ^CNY	-0.18%		-1.96%	-18.55%

06-08	KPC Pharmaceuticals,Inc agreed to acquire 51% stake in China Resources Kunming Shenghuo Pharmaceutical Co., Ltd. from China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. for CNY 1.8 billion.	CI
04-19	KPC Pharmaceuticals,Inc Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	8,165	6,559	8,379	10,707	15,812	12,863	-	-
Enterprise Value (EV) ¹	8,165	6,559	8,379	10,707	15,812	12,863	12,863	12,863
P/E ratio	18 x	14.4 x	16.5 x	27.7 x	35.4 x	21.3 x	16.5 x	13.5 x
Yield	-	-	-	-	0.96%	-	1.06%	-
Capitalization / Revenue	1.01 x	0.85 x	1.02 x	1.29 x	2.05 x	1.49 x	1.29 x	1.17 x
EV / Revenue	1.01 x	0.85 x	1.02 x	1.29 x	2.05 x	1.49 x	1.29 x	1.17 x
EV / EBITDA	-	9.2 x	10.4 x	15 x	21.1 x	13.3 x	10.8 x	9.14 x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Price to Book	-	1.47 x	1.75 x	2.15 x	2.98 x	2.21 x	1.99 x	1.77 x
Nbr of stocks (in thousands)	760,948	758,256	758,256	758,256	757,987	757,114	-	-
Reference price ²	10.73	8.650	11.05	14.12	20.86	16.99	16.99	16.99
Announcement Date	20-03-30	21-03-15	22-03-18	23-03-22	24-03-21	-	-	-

¹CNY in Million²CNY

Estimates

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	8,120	7,717	8,254	8,282	7,703	8,611	9,985	11,004
EBITDA ¹	-	712.9	806.8	713.2	749.2	969.1	1,188	1,408
EBIT ¹	-	540.8	634	497.1	568.5	782.7	1,008	1,244
Operating Margin	-	7.01%	7.68%	6%	7.38%	9.09%	10.1%	11.3%
Earnings before Tax (EBT) ¹	-	540.5	631.3	477.3	563.6	774.8	1,002	1,236
Net income ¹	-	456.9	507.7	383.2	444.7	601.3	778.4	950.9
Net margin	-	5.92%	6.15%	4.63%	5.77%	6.98%	7.8%	8.64%
EPS ²	0.5965	0.6018	0.6695	0.5100	0.5900	0.7960	1.028	1.258
Free Cash Flow	-	-	-	-	-	-	-	-
FCF margin	-	-	-	-	-	-	-	-
FCF Conversion (EBITDA)	-	-	-	-	-	-	-	-
FCF Conversion (Net income)	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	0.2000	-	0.1800	-
Announcement Date	20-03-30	21-03-15	22-03-18	23-03-22	24-03-21	-	-	-

¹CNY in Million²CNY

Estimates

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt	-	-	-	-	-	-	-	-
Net Cash position	-	-	-	-	-	-	-	-
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-
Free Cash Flow	-	-	-	-	-	-	-	-
ROE (net income / shareholders' equity)	-	10.6%	11%	7.89%	8.64%	10.3%	12%	13.1%
ROA (Net income/ Total Assets)	-	-	-	-	4.68%	5.9%	6.94%	7.2%
Assets ¹	-	-	-	-	9,499	10,191	11,216	13,207
Book Value Per Share ²	-	5.870	6.310	6.570	6.990	7.680	8.540	9.590
Cash Flow per Share ²	-	0.5400	0.3300	0.3300	0.4700	0.9500	1.050	1.350
Capex ¹	-	46.6	226	65.5	57.1	109	144	122
Capex / Sales	-	0.6%	2.74%	0.79%	0.74%	1.27%	1.45%	1.11%
Announcement Date	20-03-30	21-03-15	22-03-18	23-03-22	24-03-21	-	-	-

¹CNY in Million²CNY

Estimates

Trading Rating

Investor Rating

ESG Refinitiv

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

16.99 CNY

Average target price

25.01 CNY

Spread / Average Target

+47.20%